How India’s Cheap Weight Loss Drugs Encounters The Global Obesity Fight
The earlier weight loss drugs like
Ozempic and Wegovy are likely to expire in the country. This is beneficial for
the domestic pharmaceutical companies as they will get the chance to release
cheaper copies or generics. Due to perfect competition, the drugs may be much
cheaper; hence people all over India, and maybe other countries, may get easy
access to these medicines.
As India has decided to unveil the
low-cost generic versions of injections like Ozempic, this will definitely
transform the global fight against obesity. Earlier treatment through these
drugs was considered a luxury, mostly in middle-income countries. But the new
drug will dramatically widen access to treatments.
- Boom in Weight Loss Drugs
The worth of the Indian pharmaceutical
industry is expected to double by 2030. Generic, a manufacturing muscle, is now
targeting fierce competition over semaglutide. This injection may become far
more common, which was otherwise largely confined to affluent patients.
These Injections were originally
developed to treat diabetes. But now these are considered game changers for
weight loss as well. These injections might offer results that no previous
treatments could match. GLP-1 receptor agonists are a class of medicines that
mimic a hormone perfect to regulate appetite and blood sugar. Semaglutide
belongs to this class of medicine.
The medicine helps in slowing the
emptying of the stomach due to a boost in insulin release. This drug also helps
in staying full sooner and longer. This drug is now the most sought-after
weight loss treatment in the world, which was originally developed for
diabetes.
- India’s Health Landscape is
Shifting
According to the World Health
Organization, India is still among the undernourished countries of the world. Obesity rates are sharply increasing
due to rising income and urban lifestyles. Here, it is believed that once a
person starts earning money, they turn more sedentary. Government sources
reveal that 24 percent of women and 23 percent of men are obese in India.
In the developed countries, the more
people earn money, the more time they spend improving their health. But it is
the reverse in India.
Though there has been a tenfold growth
in the sale of weight loss drugs over the last five years. But these drugs may
also lead to side effects like gastrointestinal issues and nausea.
- No Price Barrier
Earlier, patients abandoned the idea of
treating obesity because they were worried about the high prices. Now this
price barrier no longer exists as the weight loss treatments are much cheaper
compared to the past. For commoners, prices could still be high, and it is
expected that generics are likely to reduce the treatment cost. Hence, more
people will be encouraged to beat obesity.
It is advised by the experts that the
quality of the medicine produced in India should be more regulated.
- Global Impact
India is considered the largest
supplier of generic medicines. Due to its ability to turn expensive medicines
into mass market products, India is treated as the pharmacy of the world.
Africa’s half of the generic drug
demand is fulfilled from India, as this country supplies medicines to more than
200 countries in the world. The current weight loss drug in India has huge
export potential. It’s believed that even developed countries like the USA are
going to import the medicine from India.
Comments
Post a Comment